Harry B. Carslake
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Harry B. Carslake has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Marie McGowan
University of Liverpool image/svg+xml
5 shared publications G.L. Pinchbeck
Institute of Infection, Veterinary and Ecological sciences, Faculty of Health and Life Sciences, University of Liverpool, Leahurst CH64 7TE, UK
4 shared publicationsA.H.A. Dugdale
Paragon Veterinary Referrals, Wakefield WF1 2DF, UK
3 shared publications- Annabelle E. Graham
Institute of Infection, Veterinary and Ecological Sciences University of Liverpool Liverpool UK
2 shared publications C.M. Argo
Scotland's Rural College, Aberdeen, Scotland AB21 9YA, UK
2 shared publicationsC.M. McGowan
Institute of Infection, Veterinary and Ecological sciences, Faculty of Health and Life Sciences, University of Liverpool, Leahurst CH64 7TE, UK
2 shared publications
Latest Publications
- 30 June 2026
- Published by Wiley in Equine Veterinary Journal
Risk factors for post‐partum colic in a population of UK and Irish Thoroughbred broodmares
Background: Broodmares are at increased risk of gastrointestinal colic. However, colic risk factors specific to this population have not been investigated. Objective: To investigate horse‐ and management‐level risk factors for post‐partum colic in a cohort of Thoroughbred broodmares in the United Kingdom and Ireland. Study Design: Prospective, nested case–control study. Methods: Twenty‐nine Thoroughbred stud farms in the United Kingdom and Ireland were recruited, and 1044 mares were followed over the 2021 and/or 2022 foaling seasons. Data were collected on signalment, medical and management history for post‐partum colic mares and matched (3:1) controls. Multivariable analysis was conducted using conditional logistic regression. Results: Due to strong collinearity between days post‐partum and time spent stabled, two multivariable models were built. Days post‐partum (Model 1: OR 0.9, 95% CI 0.8–0.9; p < 0.001) and increasing hours stabled (Model 2: OR 1.2, 95% CI 1.1–1.3; p < 0.001) were strongly associated with increased risk of post‐partum colic. Colic risk was highest immediately post‐partum, with reduction in likelihood of colic up to 50 days after foaling. NSAID use in the previous 28 days (Model 1: OR 6.2, 95% CI 2.0–65.5; Model 2: OR 4.1, 95% CI 1.1–15.0; p = 0.048) and a history of previous colic (Model 1: OR 7.4, 95% CI 1.2–7.9; Model 2: OR 5.3, 95% CI 1.7–17.1; p = 0.01) were also associated with increased colic risk. Calcium supplementation was associated with increased likelihood of post‐partum colic in Model 1 only (OR 4.4, 95% CI 1.3–15.7; p = 0.04). Main Limitations: Mares comprised a small sub‐population of UK and Irish Thoroughbred broodmares. Pre‐partum colic was not investigated. Conclusions: Maximising turnout in post‐partum broodmares may reduce colic risk, immediately post‐partum and up to 50 days. Broodmares who have recently received NSAIDs, have a history of colic or are receiving a calcium‐based supplement may be at increased risk of post‐partum colic.
- 30 June 2026
- Published by Wiley in Equine Veterinary Journal
Risk factors for post‐partum colic in a population of UK and Irish Thoroughbred broodmares
Background: Broodmares are at increased risk of gastrointestinal colic. However, colic risk factors specific to this population have not been investigated. Objective: To investigate horse‐ and management‐level risk factors for post‐partum colic in a cohort of Thoroughbred broodmares in the United Kingdom and Ireland. Study Design: Prospective, nested case–control study. Methods: Twenty‐nine Thoroughbred stud farms in the United Kingdom and Ireland were recruited, and 1044 mares were followed over the 2021 and/or 2022 foaling seasons. Data were collected on signalment, medical and management history for post‐partum colic mares and matched (3:1) controls. Multivariable analysis was conducted using conditional logistic regression. Results: Due to strong collinearity between days post‐partum and time spent stabled, two multivariable models were built. Days post‐partum (Model 1: OR 0.9, 95% CI 0.8–0.9; p < 0.001) and increasing hours stabled (Model 2: OR 1.2, 95% CI 1.1–1.3; p < 0.001) were strongly associated with increased risk of post‐partum colic. Colic risk was highest immediately post‐partum, with reduction in likelihood of colic up to 50 days after foaling. NSAID use in the previous 28 days (Model 1: OR 6.2, 95% CI 2.0–65.5; Model 2: OR 4.1, 95% CI 1.1–15.0; p = 0.048) and a history of previous colic (Model 1: OR 7.4, 95% CI 1.2–7.9; Model 2: OR 5.3, 95% CI 1.7–17.1; p = 0.01) were also associated with increased colic risk. Calcium supplementation was associated with increased likelihood of post‐partum colic in Model 1 only (OR 4.4, 95% CI 1.3–15.7; p = 0.04). Main Limitations: Mares comprised a small sub‐population of UK and Irish Thoroughbred broodmares. Pre‐partum colic was not investigated. Conclusions: Maximising turnout in post‐partum broodmares may reduce colic risk, immediately post‐partum and up to 50 days. Broodmares who have recently received NSAIDs, have a history of colic or are receiving a calcium‐based supplement may be at increased risk of post‐partum colic.
- Open Access
- 26 June 2025
- Published by Wiley in Equine Veterinary Journal
- Vol. 58 (3) , 692-698
Complications associated with subpalpebral lavage systems in upper and lower equine eyelids: A prospective, randomised study in 73 cases (2015–2024)
Background: Evidence for optimal location of subpalpebral lavage (SPL) systems is lacking. Objectives: To compare the rate and types of complications with SPL systems located in central upper‐ compared with medial lower‐eyelid in hospitalised patients. Study Design: Prospective, randomised treatment trial. Methods: Horses admitted for ophthalmic treatment using an SPL system from February 2015 to January 2024 were included if ocular pathology did not necessitate SPL system placement in a specific location. Coin toss was used to determine location. SPL systems were monitored at least daily, and complications were defined as major (displacement of footplate from the fornix ± corneal ulceration; loss of footplate; eyelid infection/abscess formation) or minor (loss of suture/tape; palpebral swelling; leakage or tube rupture; loss of injection port; subcutaneous swelling/abscess at suture site). Data were analysed using logistic regression. Results: Seventy‐three SPL systems in 68 horses were included, with 38 (52%) located in the upper and 35 (48%) in the lower eyelid, for a median (IQR) duration of 13 (8–16) days. Sixty‐nine complications (37 (54%) in upper and 32 (46%) in lower SPL systems) occurred in 44/73 (60%) of all SPL systems. Major complications occurred with 2 lower (2/69; 3%) and 10 upper SPL systems (10/69;14%). The most common major complication was displacement of the lavage footplate from the conjunctival fornix (7/69; 10%). The most common minor complication was loss of suture or butterfly tape (21/69; 30%). Treatment with chloramphenicol (OR = 0.3; 95% CI: 0.09–0.8; p = 0.02) or cross‐linked modified hyaluronic acid (OR = 3.9; 95% CI: 1.2–13.3; p = 0.03) was associated with any complication on multivariable analysis. Multivariable analysis showed that upper systems were 5.1 (95% CI: 1.0–25.7; p = 0.05) more likely to have a major complication than lower SPL systems. Main Limitations: Small study size. Conclusions: SPL system location had no effect on all complications, but major complications were more common in those placed in the upper lid.
- 26 June 2025
- Published by Wiley in Equine Veterinary Journal
- Vol. 58 (3) , 692-698
Open AccessComplications associated with subpalpebral lavage systems in upper and lower equine eyelids: A prospective, randomised study in 73 cases (2015–2024)
Background: Evidence for optimal location of subpalpebral lavage (SPL) systems is lacking. Objectives: To compare the rate and types of complications with SPL systems located in central upper‐ compared with medial lower‐eyelid in hospitalised patients. Study Design: Prospective, randomised treatment trial. Methods: Horses admitted for ophthalmic treatment using an SPL system from February 2015 to January 2024 were included if ocular pathology did not necessitate SPL system placement in a specific location. Coin toss was used to determine location. SPL systems were monitored at least daily, and complications were defined as major (displacement of footplate from the fornix ± corneal ulceration; loss of footplate; eyelid infection/abscess formation) or minor (loss of suture/tape; palpebral swelling; leakage or tube rupture; loss of injection port; subcutaneous swelling/abscess at suture site). Data were analysed using logistic regression. Results: Seventy‐three SPL systems in 68 horses were included, with 38 (52%) located in the upper and 35 (48%) in the lower eyelid, for a median (IQR) duration of 13 (8–16) days. Sixty‐nine complications (37 (54%) in upper and 32 (46%) in lower SPL systems) occurred in 44/73 (60%) of all SPL systems. Major complications occurred with 2 lower (2/69; 3%) and 10 upper SPL systems (10/69;14%). The most common major complication was displacement of the lavage footplate from the conjunctival fornix (7/69; 10%). The most common minor complication was loss of suture or butterfly tape (21/69; 30%). Treatment with chloramphenicol (OR = 0.3; 95% CI: 0.09–0.8; p = 0.02) or cross‐linked modified hyaluronic acid (OR = 3.9; 95% CI: 1.2–13.3; p = 0.03) was associated with any complication on multivariable analysis. Multivariable analysis showed that upper systems were 5.1 (95% CI: 1.0–25.7; p = 0.05) more likely to have a major complication than lower SPL systems. Main Limitations: Small study size. Conclusions: SPL system location had no effect on all complications, but major complications were more common in those placed in the upper lid.
- Open Access
- 27 June 2024
- Published by Wiley in Equine Veterinary Education
- Vol. 36 (12) , e295-e301
Diffuse, subcutaneous presentation of neurolymphomatosis in a horse with multicentric lymphoma
Summary: A five‐year‐old Dales gelding was presented with an eight‐week history of progressive, apparently nonpainful, cord‐like, subcutaneous masses across the face, neck, trunk and forelimbs. Physical and neurological examinations identified mild, diffuse weakness, hyperaesthesia and moderate tachycardia. Transcutaneous and transrectal ultrasonography and endoscopy of the guttural pouches confirmed marked enlargement of peripheral nerves and visible cranial nerves, respectively. Histopathology of the subcutaneous lesions was indicative of chronic lymphoplasmacytic polyneuritis with fibrosis. The horse failed to respond to treatment with glucocorticoids, showing progressive generalised weakness and was euthanised. Post‐mortem examination identified a generalised lymphadenopathy and widespread dissemination of neoplastic lymphocytes, throughout the peripheral and central nervous system, heart and liver, identified by immunohistochemistry as T‐cell rich B‐cell lymphoma. This is the first report in the veterinary literature of diffuse neurolymphomatosis presenting as visible branching subcutaneous masses.
- 27 June 2024
- Published by Wiley in Equine Veterinary Education
- Vol. 36 (12) , e295-e301
Open AccessDiffuse, subcutaneous presentation of neurolymphomatosis in a horse with multicentric lymphoma
Summary: A five‐year‐old Dales gelding was presented with an eight‐week history of progressive, apparently nonpainful, cord‐like, subcutaneous masses across the face, neck, trunk and forelimbs. Physical and neurological examinations identified mild, diffuse weakness, hyperaesthesia and moderate tachycardia. Transcutaneous and transrectal ultrasonography and endoscopy of the guttural pouches confirmed marked enlargement of peripheral nerves and visible cranial nerves, respectively. Histopathology of the subcutaneous lesions was indicative of chronic lymphoplasmacytic polyneuritis with fibrosis. The horse failed to respond to treatment with glucocorticoids, showing progressive generalised weakness and was euthanised. Post‐mortem examination identified a generalised lymphadenopathy and widespread dissemination of neoplastic lymphocytes, throughout the peripheral and central nervous system, heart and liver, identified by immunohistochemistry as T‐cell rich B‐cell lymphoma. This is the first report in the veterinary literature of diffuse neurolymphomatosis presenting as visible branching subcutaneous masses.
- Open Access
- 9 April 2024
- Published by Elsevier in The Veterinary Journal
- Vol. 305, 106110
Investigation of glucagon-like peptide-1 response to six oral carbohydrates in ponies
- 9 April 2024
- Published by Elsevier in The Veterinary Journal
- Vol. 305, 106110
Open AccessInvestigation of glucagon-like peptide-1 response to six oral carbohydrates in ponies
- Open Access
- 14 December 2023
- Published by Elsevier in The Veterinary Journal
- Vol. 303, 106059
Comparison of one novel and four established diagnostic tests for insulin dysregulation in ponies
- 14 December 2023
- Published by Elsevier in The Veterinary Journal
- Vol. 303, 106059
Open AccessComparison of one novel and four established diagnostic tests for insulin dysregulation in ponies
- Open Access
Development of a Web App to Convert Blood Insulin Concentrations among Various Immunoassays Used in Horses
The measurement of the blood insulin concentration, and comparison to cut-offs, is essential in diagnosing insulin dysregulation, a common equine endocrinopathy. However, different insulin assays provide disparate results. We aimed to ease comparison between assays by compiling original and published data into a web app to convert insulin measurements from one assay to another. Data were available for ADVIA Centaur insulin chemiluminescent immunoassay (CLIA), Beckman Coulter insulin radioimmunoassay (RIA), Immulite 1000 CLIA, Immulite 2000 CLIA, Immulite 2000 XPi CLIA, Mercodia equine insulin enzyme-linked immunosorbent assay (ELISA), and Millipore porcine insulin RIA. Linear models were fitted for 13 assay pairs using non-decreasing splines, and integrated into this app. Assay comparisons including data from several studies showed a lower performance. This indicates technical variation between laboratories, which has not been described before, but is relevant when diagnostic measurements and cut-offs are provided by different laboratories. Nevertheless, the models’ overall high performance (median r2 = 0.94; range 0.57–1.00) supports their use to interpret results from diagnostic insulin measurements when the reference assay is unavailable, and to compare values obtained from different assays.
Open AccessDevelopment of a Web App to Convert Blood Insulin Concentrations among Various Immunoassays Used in Horses
The measurement of the blood insulin concentration, and comparison to cut-offs, is essential in diagnosing insulin dysregulation, a common equine endocrinopathy. However, different insulin assays provide disparate results. We aimed to ease comparison between assays by compiling original and published data into a web app to convert insulin measurements from one assay to another. Data were available for ADVIA Centaur insulin chemiluminescent immunoassay (CLIA), Beckman Coulter insulin radioimmunoassay (RIA), Immulite 1000 CLIA, Immulite 2000 CLIA, Immulite 2000 XPi CLIA, Mercodia equine insulin enzyme-linked immunosorbent assay (ELISA), and Millipore porcine insulin RIA. Linear models were fitted for 13 assay pairs using non-decreasing splines, and integrated into this app. Assay comparisons including data from several studies showed a lower performance. This indicates technical variation between laboratories, which has not been described before, but is relevant when diagnostic measurements and cut-offs are provided by different laboratories. Nevertheless, the models’ overall high performance (median r2 = 0.94; range 0.57–1.00) supports their use to interpret results from diagnostic insulin measurements when the reference assay is unavailable, and to compare values obtained from different assays.
- Open Access
- 28 July 2022
- Published by Wiley in Equine Veterinary Education
- Vol. 35 (4) , E303-E310
Trigeminal neuropathy in two horses following trauma to the infraorbital and mental nerves
Summary: This case series describes two cases of a head injury resulting in a traumatic neuropathy of the infraorbital nerve and the mental nerve, respectively. Both cases presented with head‐shaking behaviour and assumed facial dysaesthesia. This is a cause of head‐shaking not previously described in horses. One horse (Case 1) had a small wound at the level of the infraorbital foramen and was diagnosed with a bony fragment adjacent to the infraorbital nerve using computed tomography (CT) and ultrasonography. Treatment consisted of surgical removal of the fragment, systemic anti‐inflammatories and multimodal analgesia. The second case (Case 2) was diagnosed with a nondisplaced comminuted fracture of the right hemi‐mandible using CT. The fracture line, along with multiple small fragments, was overlying the mental nerve as the nerve exits the mental foramen. The horse was treated with multimodal analgesia, and the fracture healed without requiring stabilisation. Clinical signs took several months to resolve in both cases. There were no reported signs of dysaesthesia or head‐shaking 6 months (Case 1) and 4 months (Case 2) following diagnosis. Long‐term follow‐up is still required to assess these horses. Traumatic neuropathy should be considered as a differential diagnosis in horses presenting with head‐shaking behaviour.
- 28 July 2022
- Published by Wiley in Equine Veterinary Education
- Vol. 35 (4) , E303-E310
Open AccessTrigeminal neuropathy in two horses following trauma to the infraorbital and mental nerves
Summary: This case series describes two cases of a head injury resulting in a traumatic neuropathy of the infraorbital nerve and the mental nerve, respectively. Both cases presented with head‐shaking behaviour and assumed facial dysaesthesia. This is a cause of head‐shaking not previously described in horses. One horse (Case 1) had a small wound at the level of the infraorbital foramen and was diagnosed with a bony fragment adjacent to the infraorbital nerve using computed tomography (CT) and ultrasonography. Treatment consisted of surgical removal of the fragment, systemic anti‐inflammatories and multimodal analgesia. The second case (Case 2) was diagnosed with a nondisplaced comminuted fracture of the right hemi‐mandible using CT. The fracture line, along with multiple small fragments, was overlying the mental nerve as the nerve exits the mental foramen. The horse was treated with multimodal analgesia, and the fracture healed without requiring stabilisation. Clinical signs took several months to resolve in both cases. There were no reported signs of dysaesthesia or head‐shaking 6 months (Case 1) and 4 months (Case 2) following diagnosis. Long‐term follow‐up is still required to assess these horses. Traumatic neuropathy should be considered as a differential diagnosis in horses presenting with head‐shaking behaviour.
- 24 July 2022
- Published by Wiley in Equine Veterinary Education
- Vol. 35 (4) , E234-E240
Vaccination with human tyrosinase DNA as a therapy for equine intraocular melanoma—4 cases: 2016–2021
Summary: This report describes four cases of intraocular melanoma which were treated with a course of human tyrosine DNA canine melanoma vaccine. Two cases continued to show progression of the tumour. One case presented with bilateral intraocular melanomas and demonstrated clinical progression in one eye within 5 months, and apparent quiescence of disease in the other, though subtle deterioration was noted at a 2‐year follow‐up. The final case presented with recurrent ulceration due to an intraocular melanoma and demonstrated a good clinical response with a reduction in the frequency and severity of the episodes of ulceration. The small number of cases in this report precludes firm conclusions, but these reported outcomes suggest limited justification for the routine recommendation of melanoma vaccines to horses with intraocular melanomas.
- 24 July 2022
- Published by Wiley in Equine Veterinary Education
- Vol. 35 (4) , E234-E240
Vaccination with human tyrosinase DNA as a therapy for equine intraocular melanoma—4 cases: 2016–2021
Summary: This report describes four cases of intraocular melanoma which were treated with a course of human tyrosine DNA canine melanoma vaccine. Two cases continued to show progression of the tumour. One case presented with bilateral intraocular melanomas and demonstrated clinical progression in one eye within 5 months, and apparent quiescence of disease in the other, though subtle deterioration was noted at a 2‐year follow‐up. The final case presented with recurrent ulceration due to an intraocular melanoma and demonstrated a good clinical response with a reduction in the frequency and severity of the episodes of ulceration. The small number of cases in this report precludes firm conclusions, but these reported outcomes suggest limited justification for the routine recommendation of melanoma vaccines to horses with intraocular melanomas.
- Open Access
- 30 October 2020
- Published by Wiley in Equine Veterinary Journal
- Vol. 53 (5) , 923-934
Equine metabolic syndrome in UK native ponies and cobs is highly prevalent with modifiable risk factors
Background: The epidemiology of equine metabolic syndrome (EMS) is poorly described. Objectives: To estimate the prevalence of EMS in native UK ponies and cobs in England and Wales and identify associated risk factors. Study design: Cross‐sectional study. Methods: Breeders registered with UK native pony breed societies and registered riding schools and livery yards within a set radius were invited to participate. All native UK ponies and cobs aged 3‐14 years and not diagnosed or being treated for conditions likely to affect insulin regulation at participating premises were eligible. Animals underwent a clinical examination and an oral glucose test while their owner or keeper completed a questionnaire by face‐to‐face interview. Data were analysed by multilevel uni‐ and multivariable modelling using insulin concentration and EMS diagnosis as outcomes. Results: A total of 354 animals were examined at 64 properties (19 studs, 19 livery yards, 26 riding schools). The overall prevalence of EMS adjusted for clustering within yard was 23.3% (95%CI 17.9%–29.8%). Risk factors associated with a diagnosis of EMS included age, being female, more sedentary main activity, obesity, and shorter periods on pasture during the summer. Compared to the Welsh section A, the other Welsh, Connemara and cob breeds all had decreased odds of EMS. Clinical manifestations of hoof growth ring and supraorbital fat scores of 3/3 were more frequent in EMS ponies and animals with a history of laminitis within the last 5 years (9.7%) were 14.4 (95% CI 5.9–35.3) times more likely to be positive for EMS than those without. Main limitations: Results may not be transferable to other breeds or age groups. Conclusions: Equine metabolic syndrome is highly prevalent in UK native ponies and cobs with modifiable risk factors including obesity and sedentary activities. Modifying risk factors could help reduce the risk of laminitis in susceptible animals.
- 30 October 2020
- Published by Wiley in Equine Veterinary Journal
- Vol. 53 (5) , 923-934
Open AccessEquine metabolic syndrome in UK native ponies and cobs is highly prevalent with modifiable risk factors
Background: The epidemiology of equine metabolic syndrome (EMS) is poorly described. Objectives: To estimate the prevalence of EMS in native UK ponies and cobs in England and Wales and identify associated risk factors. Study design: Cross‐sectional study. Methods: Breeders registered with UK native pony breed societies and registered riding schools and livery yards within a set radius were invited to participate. All native UK ponies and cobs aged 3‐14 years and not diagnosed or being treated for conditions likely to affect insulin regulation at participating premises were eligible. Animals underwent a clinical examination and an oral glucose test while their owner or keeper completed a questionnaire by face‐to‐face interview. Data were analysed by multilevel uni‐ and multivariable modelling using insulin concentration and EMS diagnosis as outcomes. Results: A total of 354 animals were examined at 64 properties (19 studs, 19 livery yards, 26 riding schools). The overall prevalence of EMS adjusted for clustering within yard was 23.3% (95%CI 17.9%–29.8%). Risk factors associated with a diagnosis of EMS included age, being female, more sedentary main activity, obesity, and shorter periods on pasture during the summer. Compared to the Welsh section A, the other Welsh, Connemara and cob breeds all had decreased odds of EMS. Clinical manifestations of hoof growth ring and supraorbital fat scores of 3/3 were more frequent in EMS ponies and animals with a history of laminitis within the last 5 years (9.7%) were 14.4 (95% CI 5.9–35.3) times more likely to be positive for EMS than those without. Main limitations: Results may not be transferable to other breeds or age groups. Conclusions: Equine metabolic syndrome is highly prevalent in UK native ponies and cobs with modifiable risk factors including obesity and sedentary activities. Modifying risk factors could help reduce the risk of laminitis in susceptible animals.
- Open Access
- 17 June 2020
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 34 (4) , 1599-1605
Insulin dysregulation in a population of Finnhorses and associated phenotypic markers of obesity
Background Obesity and insulin dysregulation (ID) predispose horses to laminitis. Determination of management practices or phenotypic markers associated with ID may benefit animal welfare. Objectives Determine ID status of a population of Finnhorses using an oral sugar test (OST) and compare phenotypes and management factors between ID and non‐ID Finnhorses. Animals One hundred twenty‐eight purebred Finnhorses ≥3 years of age. Methods Owners were recruited using an online questionnaire regarding signalment, history, feeding, and exercise of their horses. Selected contributing stables within a predefined area were visited. Phenotypic markers of obesity and the weight of each horse were recorded. After fasting overnight, horses received 0.45 mL/kg corn syrup PO. Serum samples before and at 60 and 90 minutes after syrup administration were analyzed for insulin by chemiluminescent assay. Horses met ID criteria if insulin concentrations were ≥33 μIU/mL at T0, ≥66 μIU/mL at T60 or T90 or some combination thereof. Associations between phenotypic markers, feeding and exercise variables, and ID were examined using mixed effects logistic regression modeling. Results Several phenotypic markers of obesity were significant on univariable analysis but in the final multivariable model, only obesity (body condition score ≥8) was associated with ID (P = .04). Over half of the horses (60% [95% confidence interval (CI), 51%‐68%]) were considered overweight or obese whereas 16% (95% CI, 10%‐23%) were classified as having ID. Conclusions and Clinical Importance Because obesity is associated with ID in cold‐blooded type horses, objective monitoring of phenotypic markers by owners may be beneficial for health outcomes.
- 17 June 2020
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 34 (4) , 1599-1605
Open AccessInsulin dysregulation in a population of Finnhorses and associated phenotypic markers of obesity
Background Obesity and insulin dysregulation (ID) predispose horses to laminitis. Determination of management practices or phenotypic markers associated with ID may benefit animal welfare. Objectives Determine ID status of a population of Finnhorses using an oral sugar test (OST) and compare phenotypes and management factors between ID and non‐ID Finnhorses. Animals One hundred twenty‐eight purebred Finnhorses ≥3 years of age. Methods Owners were recruited using an online questionnaire regarding signalment, history, feeding, and exercise of their horses. Selected contributing stables within a predefined area were visited. Phenotypic markers of obesity and the weight of each horse were recorded. After fasting overnight, horses received 0.45 mL/kg corn syrup PO. Serum samples before and at 60 and 90 minutes after syrup administration were analyzed for insulin by chemiluminescent assay. Horses met ID criteria if insulin concentrations were ≥33 μIU/mL at T0, ≥66 μIU/mL at T60 or T90 or some combination thereof. Associations between phenotypic markers, feeding and exercise variables, and ID were examined using mixed effects logistic regression modeling. Results Several phenotypic markers of obesity were significant on univariable analysis but in the final multivariable model, only obesity (body condition score ≥8) was associated with ID (P = .04). Over half of the horses (60% [95% confidence interval (CI), 51%‐68%]) were considered overweight or obese whereas 16% (95% CI, 10%‐23%) were classified as having ID. Conclusions and Clinical Importance Because obesity is associated with ID in cold‐blooded type horses, objective monitoring of phenotypic markers by owners may be beneficial for health outcomes.